Futura Medical plc
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Fut… Read more
Market Cap & Net Worth: Futura Medical plc (FAMDF)
Futura Medical plc (PINK:FAMDF) has a market capitalization of $69.76 Million ($69.76 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #30404 globally and #10021 in its home market, demonstrating a -36.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Futura Medical plc's stock price $0.12 by its total outstanding shares 581327755 (581.33 Million).
Futura Medical plc Market Cap History: 2015 to 2025
Futura Medical plc's market capitalization history from 2015 to 2025. Data shows change from $234.10 Million to $69.76 Million (-12.33% CAGR).
Futura Medical plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Futura Medical plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
19.62x
Futura Medical plc's market cap is 19.62 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
211.31x
Futura Medical plc's market cap is 211.31 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $234.10 Million | $29.48K | -$5.08 Million | 7942.08x | N/A |
| 2016 | $387.28 Million | $170.36K | -$3.70 Million | 2273.28x | N/A |
| 2017 | $202.30 Million | $362.73K | -$3.90 Million | 557.73x | N/A |
| 2019 | $87.20 Million | $31.78K | -$8.92 Million | 2744.01x | N/A |
| 2023 | $203.46 Million | $3.10 Million | -$6.51 Million | 65.61x | N/A |
| 2024 | $273.22 Million | $13.93 Million | $1.29 Million | 19.62x | 211.31x |
Competitor Companies of FAMDF by Market Capitalization
Companies near Futura Medical plc in the global market cap rankings as of March 19, 2026.
Key companies related to Futura Medical plc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Futura Medical plc Historical Marketcap From 2015 to 2025
Between 2015 and today, Futura Medical plc's market cap moved from $234.10 Million to $ 69.76 Million, with a yearly change of -12.33%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $69.76 Million | -74.47% |
| 2024 | $273.22 Million | +34.29% |
| 2023 | $203.46 Million | -43.55% |
| 2022 | $360.42 Million | +16.98% |
| 2021 | $308.10 Million | +178.95% |
| 2020 | $110.45 Million | +26.67% |
| 2019 | $87.20 Million | +200.00% |
| 2018 | $29.07 Million | -85.63% |
| 2017 | $202.30 Million | -47.76% |
| 2016 | $387.28 Million | +65.43% |
| 2015 | $234.10 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Futura Medical plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $69.76 Million USD |
| MoneyControl | $69.76 Million USD |
| MarketWatch | $69.76 Million USD |
| marketcap.company | $69.76 Million USD |
| Reuters | $69.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.